U
biquitin (Ub) is a small, heat stable, and highly conserved protein in all eukaryotic cells. [1] [2] [3] It fulfills its major biologic role through covalent ligation (ubiquitylation or ubiquitination) to intracellular proteins, and thus labels the target protein for degradation via the proteasome or reversibly regulates the targeted protein's function. 3 Today, ubiquitylation is regarded as the second most common posttranslational protein modification after phosphorylation. 4 -6 Although the discovery of Ub introduced this protein as a molecule with extracellular actions, 1 little attention has since been paid to its possible role outside the cell. Ub is a natural constituent of extracellular fluids, such as serum, plasma, or cerebrospinal fluid, and increased extracellular concentrations have been described in some diseases. 1, [7] [8] [9] [10] [11] [12] However, no pathophysiologic role was attributed to extracellular Ub in these studies.
Recently, we showed that Ub is systemically released after trauma and sepsis in patients, that it is involved in the regulation of leukocyte function and inhibits the lipopolysaccharide-(LPS)-evoked tumor necrosis factor-␣ and interleukin-8 response of blood and isolated peripheral blood mononuclear cells in vitro. 13, 14 Because other investigators provided evidence that it also regulates growth and apoptosis, and possesses antimicro-bial activity, [15] [16] [17] extracellular Ub may have pleiotropic effects on host defense mechanisms. Subsequently, we were able to confirm Ubs immune modulatory properties in vivo and showed that it has profound anti-inflammatory effects in various models of infectious and noninfectious inflammation. 18 -22 Altogether, these data suggest that Ub is an endogenous anti-inflammatory mediator that could play an important role during the inflammatory response to mechanical and thermal injury. However, its association with injury severity and outcomes in blunt trauma patients is unknown and Ub release after thermal injuries has not been studied. Therefore, we conducted a prospective observational trial in blunt trauma and burned patients to evaluate whether Ubs systemic concentrations are associated with injury severity, development of severe posttraumatic complications, and survival.
PATIENTS AND METHODS

Patients, Participants, and Study Protocol
The Institutional Review Boards of the Universities of Miami, Berlin, Munich, and Essen approved the protocol that we used. Informed consent was obtained from all participants. The study population comprised of 129 patients with blunt injuries and 55 patients with burns who were admitted to the emergency room of the participating hospitals, and of 50 healthy blood donors. Exclusion criteria were age under 18 years, hospital admission later than 6 hours after injury, transfer from other hospitals and severe preexisting infectious, and immunologic or cardiovascular diseases that required long-term medication. Sixty-six blunt trauma patients were recruited in Miami, 53 in Berlin, and 10 in Essen. Burned patients were recruited in Munich. Healthy blood donors were recruited in Miami (n ϭ 20), Munich (n ϭ 20), and Essen (n ϭ 10). Blood donors (age: 43 Ϯ 11 years [mean Ϯ SD]; 68% male), had no signs of infection at least 4 weeks before the blood draw.
All patients requiring surgical intervention received standard surgical care and postoperative intensive care unit (ICU) treatment according to the standard treatment protocols of the individual hospitals. For the assessment of injury severity in blunt trauma patients, the Injury Severity Scores (ISS) were calculated based on the final patient records. 23 In burned patients injury severity was assessed by the percentage of at least second-degree burned total body surface area (%TBSA), as documented in the patient records. All patients were prospectively observed for the development of severe sepsis, septic shock, or multiple organ failure (sepsis/MOF). Severe sepsis and septic shock were diagnosed according to the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) consensus conference criteria. 24 MOF was diagnosed using a scoring system modified according to Goris et al. [25] [26] [27] In brief, failure of a single organ was assumed when the following criteria were present for at least 3 consecutive days: lung, mechanical ventilation with positive end-expiratory pressure (PEEP) Ͼ10 cm H 2 O and/or FIO 2 Ͼ0.4; heart, dopamine Ͼ700 g or catecholamine treatment; kidney, hemofiltration or hemodialysis; liver, bilirubin Ͼ102 mol/L or aspartate aminotransferase (AST) Ͼ100 U/L; blood, hemorrhagic diathesis or leukocytes Ͼ60 k/L or Ͻ2.5 k/L; gastrointestinal, parenteral nutrition; brain, treatment for increased intracranial pressure. MOF was diagnosed when these criteria were fulfilled for two or more organs. Because MOF without positive criteria of severe sepsis or septic shock after blunt trauma and burns was expected to be rare, these posttraumatic complications were combined and documented as sepsis/MOF positive or negative. In addition, in burned patients the sepsis-related organ failure or sequential organ failure assessment (SOFA) scores 28, 29 were calculated daily and the volumes of fluids infused and urine output were documented.
Duration of ICU treatment and hospital survival were documented based on the final patient records. The epidemiologic and clinical characteristics of the blunt trauma and burned patients are shown in Table 1 .
Venous blood samples (1-2 mL) were drawn immediately after admission to the emergency room (day 0) and in the morning of the subsequent days 1, 3, 5, and 7 between 7 AM and 9 AM along with the routine laboratory work-up. Because blood samples could not be obtained from each patient at each individual time point, the exact number of analyzed blood samples is provided for each time point in the Results section. Blood samples were collected in serum test tubes, which were in routine use in the participating hospitals, serum prepared according to the standard hospital procedures and stored at -70°C until further analysis. After all blood samples were collected and patient data recorded, Ub serum concentrations were determined with the investigators blinded to the patient-related data.
Ubiquitin Enzyme-Linked Immunosorbent Assay (ELISA)
Ub serum concentrations were quantified with a competitive ELISA, in which biotinylated Ub and Ub in the test sample compete for a limited number of binding sites in the 
Statistical Analysis
Data are described as mean Ϯ SD and are presented in the graphs as mean Ϯ SEM along with the exact number of measurements to improve the interpretation of the data. 30 Differences in Ub serum concentrations were analyzed using Student's t test or analysis of variance with Tukey post hoc correction to correct for multiple testing. Correlations were assessed using Spearman correlation coefficients (r s ) and partial correlation coefficients (r p ) that describe the relationship between two variables while controlling for the effects of one or more additional variables. Statistical analyses were calculated with the SPSS for windows program (SPSS Inc., Chicago, IL). Differences were considered significant on a two-tailed p Ͻ 0.05 level.
RESULTS
The time course of Ub serum concentrations in trauma and burned patients is shown in Figure 1A and B. Ub serum levels were significantly elevated in both patient populations, as compared with healthy volunteers (n ϭ 50, 118 ng/mL Ϯ 76 ng/mL Ub). Ub serum concentrations and their time-dependent changes after blunt trauma were similar in patients from all study sites (Fig. 1A, inserts) . Peak levels were detectable at admission (day 0, n ϭ 116, 359 ng/mL Ϯ 205 ng/mL) and normalized within 3 days after blunt trauma. Burned patients showed significantly higher Ub serum concentrations at admission (day 0, n ϭ 37, 573 ng/mL Ϯ 331 ng/mL) than blunt trauma patients ( p Ͻ 0.001). In contrast to trauma patients, Ub serum concentrations in burned patients remained elevated within the 7 days observation period.
The initial Ub serum concentrations (day 0) correlated significantly with injury severity and duration of ICU treat- Figure 2A shows the initial Ub serum levels after blunt trauma when patients were grouped according to their ISS. Although Ub levels increased with an increase in ISS, they did not differentiate patients with an ISS of 1 to 9 up to patients with an ISS of 30 to 39. Only trauma patients with an ISS of more than 39 had significantly higher Ub serum levels (n ϭ 13, 592 ng/mL Ϯ 377 ng/mL) than all other injured patients (ISS 1-9 [n ϭ 9]: 305 ng/mL Ϯ 108 ng/mL; ISS 10 -19 [n ϭ 17]: 370 Ϯ 165; ISS 20 -29 (n ϭ 49): 319 ng/mL Ϯ 155 ng/mL; ISS 30 -39 [n ϭ 23]: 377 ng/mL Ϯ 158 ng/mL). Similarly, blunt trauma patients who did not require ICU treatment (ISS: 13 Ϯ 11) had significantly lower Ub serum levels at admission (289 ng/mL Ϯ 141 ng/mL) than patients with more than 7 days of ICU treatment (ISS: 30 Ϯ 11; 420 ng/mL Ϯ 238 ng/mL) (Fig. 2C) .
When burned patients were grouped according to their %TBSA Ub serum levels on day 0 increased from 321 ng/ mL Ϯ 91 ng/mL with Ͻ25% TBSA (n ϭ 9) to 465 ng/mL Ϯ 175 ng/mL (n ϭ 10), 697 ng/mL Ϯ 412 ng/mL (n ϭ 11) and 713 ng/mL Ϯ 356 ng/mL (n ϭ 7) with 25% to 35%TBSA, 35% to 46%TBSA, and more than 46%TBSA, respectively (Fig. 2B) . Furthermore, the presence of inhalation injury was associated with significantly higher Ub concentrations ( Fig.  2B ; no inhalational injury [n ϭ 27]: 506 ng/mL Ϯ 342 ng/mL; inhalational injury [n ϭ 10]: 782 ng/mL Ϯ 254 ng/mL; p ϭ 0.029). Surprisingly, the initial Ub serum levels were significantly lower in burned patients who required ICU treatment for more than 30 days (36% Ϯ 10% TBSA; 501 ng/mL Ϯ 193 ng/mL) than in patients with a shorter duration of ICU treatment (43% Ϯ 14% TBSA;779 ng/mL Ϯ 774 ng/mL; p ϭ 0.03) (Fig. 2C) .
Ub concentrations showed no sex or age-related differences and no differences between blunt trauma patients with and without development of sepsis/MOF or blunt trauma survivors and nonsurvivors at any time point (Fig. 3) .
Because we did not detect time-related changes of Ub serum levels after burns, the correlations between Ub concentrations, %TBSA, fluid balance (fluids infused minus urine output), age, sex, SOFA scores, and outcomes were analyzed for the 7 days observation period ( Table 2 ). In a bivariate correlation analysis, Ub levels correlated significantly positive with %TBSA and negative with SOFA scores and sepsis/MOF development. As expected, %TBSA, age, fluid balance, and SOFA scores also correlated with outcomes. Thus, we used partial correlation analyses to adjust Ubs correlation with outcome for possible confounding factors (Table 3) . When correlations with sepsis/MOF development and survival were corrected for the effects of all other variables, Ub concentrations, as well as age and %TBSA correlated significantly with sepsis/MOF development and survival. In contrast, fluid balances during the entire obser- 
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Ub serum levels showed no differences when burned patients were grouped by age and sex ( Fig. 4A and B) . As indicated by the correlation analyses, burned patients with development of sepsis/MOF had a significantly higher %TBSA than patients without development of this complication (sepsis/MOF [n ϭ 25] 48% Ϯ 15%TBSA; no sepsis/ MOF [n ϭ 30] 32% Ϯ 13% TBSA; p Ͻ 0.001) and their average Ub serum concentration during the 7 days observation period was significantly lower (sepsis/MOF: 459 ng/ mL Ϯ 274 ng/mL; no sepsis/MOF: 591 ng/mL Ϯ 421 ng/mL; p Ͻ 0.05). This difference was even more pronounced when burned patients with sepsis/MOF development were compared with patients without this complication who were matched for %TBSA (n ϭ 12, 42% Ϯ 9%TBSA; p Ͼ 0.05 vs. burned patients with sepsis/MOF development; 904 ng/mL Ϯ 438 ng/mL, p Ͻ 0.001 vs. burned patients with sepsis/MOF development). Similarly, burned patients who died (n ϭ 13; 54% Ϯ 15% TBSA) had significantly lower average Ub serum concentrations (474 ng/mL Ϯ 300 ng/mL) than survivors with similar injury severity (n ϭ 14, 46% Ϯ 11%TBSA, p Ͼ 0.05 vs. nonsurvivors; 838 ng/mL Ϯ 392 ng/mL, p Ͻ 0.001 vs. nonsurvivors).
The Ub levels on the individual days of the observation period in burned patients with and without sepsis/MOF development and in survivors and nonsurvivors with burns are shown in Figures 5 and 6 , respectively. Patients who developed sepsis/MOF had significantly lower Ub serum levels on days 1 to 7 than patients with a comparable burn size who recovered uneventfully (Fig. 5A) . The total volumes of fluids infused (Fig. 5B) , urine output (Fig. 5C) , and hematocrit values (Fig. 5D) were similar between these groups. The comparison of survivors and nonsurvivors with burns showed the same tendency and group differences reached a level of statistical significance on days 5 and 7 after injury (Fig. 6A-D) .
The SOFA scores during the observation period averaged 6 Ϯ 2.5 in burned patients with development of sepsis/ MOF and 2.5 Ϯ 1.4 in burned patients who recovered uneventfully ( p Ͻ 0.001). Average SOFA scores were 3.3 Ϯ 2 and 7 Ϯ 2.8 in burned survivors and nonsurvivors, respectively ( p Ͻ 0.001). As shown in Figure 7A , Ub serum levels in the entire population of burned patients were significantly higher on days with SOFA scores of 0 to 1 than on days with SOFA scores of 2 or higher. After exclusion of patients with inhalation injury, Ub concentrations were also significantly higher on days with SOFA scores of 2 to 6 than on days with SOFA scores of more than 7 (Fig. 7B) .
DISCUSSION
This is the first description of Ub serum concentrations after burn injuries and the initial association of Ub serum levels with injury severity and outcomes after blunt trauma and burns in patients. There are several new findings from the present study: first, Ub release increases with increased injury severity after mechanical and thermal injury. Second, high amounts of Ub are systemically released in burned patients. Third, in contrast to blunt trauma patients, Ub is not cleared from the systemic circulation within the first week in burned patients. Fourth, Ub serum levels in burned patients who develop sepsis/MOF and in those who die after burns are lower than in patients with comparable injury severity who recover uneventfully or survive. Fifth, low Ub concentrations are associated with a higher degree of organ dysfunction or failure after burns. The Ub serum concentrations and their time-related changes that were detected by ELISA in the present study confirm our initial measurements in a small number of blunt trauma patients, that were detected previously using a competitive binding immunoassay. 13 The finding that Ub serum levels at admission correlate with injury severity in both trauma populations indicates passive release from damaged tissues as its major cellular source. Because we showed recently that the lung is among the organs that contain the highest concentrations of free intracellular Ub per gram of tissue, the increased Ub serum concentrations in burned patients with additional inhalation injury further support this assumption. 31 In line with cell damage as major cellular source of Ub, we did not detect any age or sex-related differences after blunt trauma or burns. In contrast to the ISS that was used to assess injury severity in blunt trauma patients, %TBSA is a measure of the overall size of injured tissue. Thus, the stronger correlation between Ub levels and %TBSA than between Ub levels and ISS further indicates Ub as a marker of cell damage. Because the serum half-life of extracellular Ub is approximately 1 hour, 18 -20 the finding that it is not cleared from the systemic circulation after burns suggests ongoing cell damage for at least 1 week. 
(analysis of variance/Tukey). (B-D) Same patients as in (A). No sepsis/MOF (open circles). No sepsis/MOF -%TBSA matched (open squares). Sepsis/MOF (grey circles). (B) Fluids infused (mL/24 h). (C) Urine output (mL/24 h). (D) Hematocrit (%).
Because it has been shown that Ub is also stored together with catecholamines in secretory granules of chromaffin cells in the adrenal medulla and secreted with catecholamines into the circulation upon chromaffin cell stimulation, its release during the stress response could also contribute to its systemic concentrations. 17 However, patients who were admitted to the emergency room after an accident but did not suffer from any injuries (ISS 0) did not show a significant increase in Ub serum concentrations, as compared with healthy volunteers. Thus, the contribution of Ub that is actively secreted during the stress response to its overall concentration in the systemic circulation after blunt trauma and burns is probably small.
Although Ub serum levels were not associated with sepsis/MOF development or survival after blunt trauma, significantly lower Ub concentrations were detectable in burned patients with poor outcomes and Ub concentrations after burns correlated significantly negative with SOFA scores. This association with poor clinical outcome and organ dysfunction or failure explains the negative correlation of its concentrations with the duration of ICU treatment.
We showed previously that Ub has multiple antiinflammatory effects in vitro and in vivo. Ub inhibited the LPS evoked tumor necrosis factor-␣ and interleukin-8 responses of whole blood and peripheral blood mononuclear cells in vitro and in vivo 13, 14, 18 and also enhanced the anti-inflammatory Th2 tissue cytokine response during inflammation in vivo. 22 These immunologic effects were accompanied by a significant reduction of third spacing of fluids in models of endotoxic shock, traumatic shock, and lung ischemia-reperfusion injury. 18 -22 Although the exact mechanism of Ubs actions is currently not known, it was 
(analysis of variance/Tukey). (B-D) Same patients as in (A). Survived (open circles). Survived -%TBSA matched (open squares). Died (grey circles). (B) Fluids infused (mL/24 h). (C) Urine output (mL/24 h). (D) Hematocrit (%).
shown previously that extracellular Ub can be taken up into intact cells, followed by covalent ligation of extracellular Ub to intracellular proteins. 16, 32 Because its uptake showed saturation kinetics with a K d value in the low nM range, 32 these data strongly suggest a highly specific receptor through which Ub mediates its actions.
Burn injuries are always associated with a profound inflammatory response and significant fluid shifts into tissues during the early postburn period, which in turn contribute to the development of organ dysfunction and failure. [33] [34] [35] [36] Therefore, the findings of the present study suggest that Ub release could constitute an endogenous defense mechanism that is aimed to limit inflammation and possibly impaired microvascular permeability. Although effects of Ub on immune functions have been described at physiologic relevant concentrations, its effects on fluid shifts were detectable when doses were administered that produced supraphysiologic concentrations. 13,14,18 -22 This may explain the observation that Ub concentrations were not associated with fluid balances in the present study. However, because observational studies cannot address any functional aspects, further mechanistic studies are required to evaluate this hypothesis. In contrast to the homogenous population of patients with thermal injuries, the heterogeneity of the individual injuries in blunt trauma patients and the variability of the physiologic response to blunt trauma could explain the missing association of Ub levels with outcomes in this patient population.
Comparison of the fluid balance and hematocrit values between patients with and without sepsis/MOF or burned survivors and nonsurvivors did not show differences in our patient population. Thus, high volumes of resuscitation fluids that possibly could have caused a dilution effect in patients with poor outcomes cannot account for the lower Ub concentrations. Other possible explanations could be increased renal secretion or Ub consumption. Because we showed that only 10% of intravenously administered exogenous Ub can be recovered in the urine, 20 increased consumption appears to be more likely to account for the lower Ub concentrations in burned patients with poor clinical outcome. Besides increased proteolytic degradation of Ub as one possible explanation, enhanced uptake could also explain the lower concentrations that were associated with sepsis/MOF or death after burns. 16, 32 In conclusion, the findings of the present study strongly suggest that systemic Ub concentrations reflect the extent of tissue damage after blunt trauma and burns in patients. Furthermore, burn patients who develop sepsis/ MOF or die seem to have a relative Ub deficiency. Although the wide range of Ub serum concentrations in injured patients shows that its levels will probably not be useful as a diagnostic or prognostic marker in the clinical arena, the results of the present study imply that Ub could play an important pathophysiologic role during the whole body response to burn injury and suggest that its systemic release is protective. Further mechanistic studies are required to confirm this hypothesis.
Because pharmacologic interventions that prevent fluid leakage into the extravascular compartment after thermal injury are not available, the results from the present study along with Ubs ability to reduce fluid shifts during infectious and noninfectious inflammation in vivo 18 -20,22 provide a strong rationale to assess Ubs therapeutic potential also after burn injuries.
shifts, we also showed directly that it significantly reduced wet-weight dry-weight ratios of the lung after ischemiareperfusion injury.
The last question by Dr. Billiar was with regard to a ubiquitin receptor. We recently provided initial evidence for a receptor for ubiquitin on monocytes that can be up-regulated during inflammation. We showed that ubiquitin is taken up into the cell and then rapidly conjugated to intracellular proteins, thus being introduced into the endogenous ubiquitin proteasome system of the target cell. This uptake showed saturation kinetics and a Kd value in the very low nanomolar range, which strongly suggests a highly specific receptor mediated uptake process. However, this putative receptor has not been identified yet.
Once again, I'd like to thank all discussants for their comments and questions.
